Ignite Creation Date:
2025-12-25 @ 2:46 AM
Ignite Modification Date:
2025-12-30 @ 11:17 PM
Study NCT ID:
NCT01313533
Status:
UNKNOWN
Last Update Posted:
2019-04-04
First Post:
2011-03-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Biologically Modified Saphenous Vein Transplants for Improved CABG Outcomes
Sponsor:
St. Luke's Hospital, Chesterfield, Missouri
Organization:
Study Overview
Official Title:
Biologically Modified Saphenous Vein Transplants for Improved CABG Outcomes
Status:
UNKNOWN
Status Verified Date:
2019-04
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to study the effects of polyarginine treated vein grafts on graft patency for patients undergoing coronary artery bypass surgery.
Detailed Description:
Double blind study with Lactated Ringers Solution and Lactated Ringers Solution with Arginine soaked for 10 minutes prior to grafting on the coronary arteries.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: